MedPath

The effect of intrauterine injection of human chorionic gonadotropin (hCG) before embryo transfer on the implantation and pregnancy rates in the intracytoplasmic sperm injection (ICSI)

Phase 2
Conditions
Infertility.
In vitro fertilization
Registration Number
IRCT2013060913605N1
Lead Sponsor
Avicenna Infertility Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
121
Inclusion Criteria

Inclusion Criteria: age between 20 and 40 yr; infertility due to male factor, PCO, or with unknown cause; informed consent from couples; obtaining high quality embryos

Exclusion criteria: azoospermia or severe oligoasthenoteratospermia; previous successful or failed IVF/ICSI; myometrium or any uterus abnormality; previous myomectomy; moderate to severe endometriosis; hydrosalpynx; obtaining more than 20 ovums or probable OHSS; nonadherence to the study protocol

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Implantation rate. Timepoint: 2 weeks after embryo transfere. Method of measurement: Serum level of B-hCG (mIU/ml) based on laboratory report.;Pregnancy rate. Timepoint: 3 weeks after positive serum B-hCG. Method of measurement: Detection of gestational sac by ultrasonographic exam.
Secondary Outcome Measures
NameTimeMethod
Serum level of B-hCG. Timepoint: 2 weeks after embryo transfere. Method of measurement: mIU/ml based on laboratory report.
© Copyright 2025. All Rights Reserved by MedPath